73 related articles for article (PubMed ID: 2232884)
1. Comparison of outcome, clinical, laboratory, and immunological features in 164 children and adults with T-ALL. The Groupe d'Etude Immunologique des Leucémies.
Garand R; Vannier JP; Béné MC; Faure G; Favre M; Bernard A
Leukemia; 1990 Nov; 4(11):739-44. PubMed ID: 2232884
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucémies.
Garand R; Voisin S; Papin S; Praloran V; Lenormand B; Favre M; Philip P; Bernier M; Vanhaecke D; Falkenrodt A
Leukemia; 1993 Feb; 7(2):161-7. PubMed ID: 8426469
[TBL] [Abstract][Full Text] [Related]
3. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
[TBL] [Abstract][Full Text] [Related]
4. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
7. [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
Ludwig WD; Teichmann JV; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
Klin Padiatr; 1990; 202(4):243-52. PubMed ID: 2203938
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates.
Yanada M; Jinnai I; Takeuchi J; Ueda T; Miyawaki S; Tsuzuki M; Hatta Y; Usui N; Wada H; Morii T; Matsuda M; Kiyoi H; Okada M; Honda S; Miyazaki Y; Ohno R; Naoe T
Leuk Res; 2007 Jul; 31(7):907-14. PubMed ID: 17005250
[TBL] [Abstract][Full Text] [Related]
9. Immunologic analysis of a thousand cases of acute leukemia. French Groupe d'Etude Immunologique des Leucémies (GEIL).
Béné MC; Boumsell L; Vannier JP; Garand R; Solary E; Faure G; Bernard A
Nouv Rev Fr Hematol (1978); 1989; 31(2):133-6. PubMed ID: 2671926
[TBL] [Abstract][Full Text] [Related]
10. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
11. [Immunological subtypes of childhood T-cell acute lymphoblastic leukemia and their prognostic significance].
Proleskovskaia IV; Buglova SE; Aleĭnikova OV
Vopr Onkol; 2002; 48(3):322-6. PubMed ID: 12455355
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
Klobusická M; Babusíková O
Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
14. A new approach of acute lymphoblastic leukemia immunophenotypic classification: 1984-1994 the GEIL experience. Groupe d'Etude Immunologique des Leucémies.
Garand R; Béné MC
Leuk Lymphoma; 1994; 13 Suppl 1():1-5. PubMed ID: 7915591
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Shuster JJ; Falletta JM; Pullen DJ; Crist WM; Humphrey GB; Dowell BL; Wharam MD; Borowitz M
Blood; 1990 Jan; 75(1):166-73. PubMed ID: 1688495
[TBL] [Abstract][Full Text] [Related]
16. Refractory T cell acute lymphoblastic leukemia with unusual karyotype and interesting immunophenotype.
Anreder MB; Mitruka BM; Gill J; Varela M; Rozans MK; Krause JR
J La State Med Soc; 1996 Dec; 148(12):521-4. PubMed ID: 8990795
[TBL] [Abstract][Full Text] [Related]
17. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
19. Shifts in expression of immunological cell markers in relapsed acute leukemia.
Tomová A; Babusíková O
Neoplasma; 2001; 48(3):164-8. PubMed ID: 11583283
[TBL] [Abstract][Full Text] [Related]
20. CD2 + CD19 + acute lymphoblastic leukaemia in 16 children and adults: clinical and biological features. Groupe d'Etude Immunologique des Leucémies (G.E.I.L.).
Lenormand B; Vannier JP; Bene MC; Falkenrodt A; Bayle C; Favre M; Garand R; Griveau AM; Briquet MT; Reman O
Br J Haematol; 1993 Apr; 83(4):580-8. PubMed ID: 7686033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]